Saturday, January 15, 2011

Supreme Court agrees to hear pharma data-mining case


After several years of courtroom battles, the U.S. Supreme Court granted cert to decide whether a state can ban data mining (i.e., tracking the sale of prescription drug information that identifies prescribers and patients for commercial marketing purposes). 

Below are the briefs for the State of Vermont (petitioner), IMS Health, Inc. (respondent), and the Pharmaceutical Research and Manufacturers of America (amicus).   

Some pharma companies use data-mining to track whether their off-label marketing techniques are effective.  It will be interesting to see whether the U.S. Attorney General and other state attorneys general file briefs.  Stay tuned, this is a very important case for health care fraud.  

Here is the State of Vermont's brief:
Vermont Cert Petition - Sorrell v IMS Health Dec 10                                                            
Here is IMS Health, Inc.'s brief:

IMS Response to Vermont Cert Petition Dec 10                                                            


Here is PhRMA's amicus brief:

PhRMA Response to Vermont Cert Petition Dec 10                                                            

 

No comments:

Post a Comment